On 12 de nov. de 2025, MNOV reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 41.18% surprise. Revenue reached 123.32 mil, compared to an expected --, with a --% difference. The market reacted with a -1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an aumentar of 83.33% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Medicinova, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Medicinova, Inc. reported EPS of -$0.06, beating estimates by 41.18%, and revenue of $123.32K, -- -- expectations.
How did the market react to Medicinova, Inc.'s Q3 2025 earnings?
The stock price moved down -1.91%, changed from $1.57 before the earnings release to $1.54 the day after.
When is Medicinova, Inc. expected to report next?
The next earning report is scheduled for 17 de fev. de 2026.
What are the forecasts for Medicinova, Inc.'s next earnings report?
Based on 4
analistas, Medicinova, Inc. is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.